Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2019 Jun 6;33(7):e22952. doi: 10.1002/jcla.22952

Expression profiles of circular RNAs in human colorectal cancer based on RNA deep sequencing

Jiaxin Ge 1,2, Yanping Jin 1, Xueyou Lv 1, Qi Liao 2, Cong Luo 3, Guoliang Ye 1, Xinjun Zhang 1,
PMCID: PMC6757124  PMID: 31169949

Abstract

Background

Circular RNAs (circRNAs) are a novel group of RNAs and play essential roles in cancers. However, the expression profiles of circRNAs in human colorectal cancer (CRC) are largely unclear.

Methods

The differentially expressed circRNAs, mRNAs, and microRNAs (miRNAs) between CRC tissues and paired adjacent normal tissues were first screened. Then, gene ontology and pathway analyses were performed to predict the possible functions. In addition, we identified the differentially expressed circRNAs in CRC correlated with Krüppel‐like factor 4 (KLF4) and validated their expression levels in CRC tissues. Finally, the correlations between hsa_circ_0142527 expression levels and clinicopathological features of patients with CRC were also analyzed.

Results

After filtered 4735 circRNAs by RNA deep sequencing, 67 differentially expressed circRNAs (fold change >2.0, P < 0.05) were selected. The top two pathways were cell cycle and other glycan degradation. Hsa_circ_0142527 and KLF4 mRNA were significantly lower expressed in CRC tissues in both training and confirm groups and have high positive correlation (r = 0.754). We further found that the expression levels of hsa_circ_0142527 were significantly associated with age (P = 0.004), differentiation (P = 0.008), invasion (P = 0.029), distal metastasis (P = 0.004), TNM stage (P = 0.005), and carcinoembryonic antigen (CEA; P = 0.037).

Conclusions

The circRNA expression profile of CRC provided new clues for understanding the occurrence of CRC. Hsa_circ_0142527 may be served as a potential biomarker for the diagnosis of CRC.

Keywords: circular RNA, colorectal cancer, hsa_circ_0142527, KLF4, RNA deep sequencing

1. INTRODUCTION

Colorectal cancer (CRC) is the third most widespread cancer in men and the second most widespread in women recently. Although screening diagnostic technique like colonoscopy and therapy involved in CRC has made great progress, CRC is fourth in mortality from cancer worldwide.1 It is indispensable to find new early diagnostic biomarkers and explore the underlying molecular mechanism of CRC to improve detection rates for early CRC patients and reduced mortality in advanced CRC patients.

Circular RNA (circRNA) is a large number of endogenous RNA in eukaryote, which is a single‐stranded RNA that has a covalent closed loop with no 5′ and 3′ ends.2 CircRNAs may arise from exons or introns of pre‐mRNA by back‐splicing.3 Interestingly, they play distinctive roles in gene expression regulation and biological processes, participating in serving as microRNA (miRNA) sponge, transcription regulation, rolling circle translation, generating pseudogenes, and affecting alternative splicing.4 Recent evidence suggested that circRNAs were closely related to human cancers including CRC mainly through acting as miRNA sponges that can bind with miRNAs to regulate their target genes which having similar miRNA response element (MRE).3, 5, 6

Up to date, RNA deep sequencing, which is gradually replacing in microarrays, has a greater dynamic range compared with microarrays.7 In this study, we explored circRNAs in CRC based on RNA deep sequencing and screened differentially expressed circRNAs. Meanwhile, we analyzed the networks among mRNAs, miRNAs, and circRNAs. We performed gene ontology (GO) and pathway analyses of the differentially expressed circRNAs, especially identified them in CRC tissues correlated with Krüppel‐like factor 4 (KLF4), one of CRC‐associated transcription factors. Among them, we randomly selected hsa_circ_0142527 as a targeted circRNA to validate the expression levels in CRC tissues. Its gene is located at chr8_68038292_68022036 with a spliced length of 503 nt. Our results, for the first time, indicated that hsa_circ_0142527 may be served as a potential biomarker for the diagnosis of CRC.

2. MATERIALS AND METHODS

2.1. Patients and specimens

All specimens were collected from two hospitals in different provinces in China. Forty‐one pairs of CRC tissues and their matched adjacent nontumorous tissues were obtained from surgical patients who were histologically confirmed to have CRC between 2016 and 2017 in the Center Gastroenterology of the Affiliated Hospital of Medical School of Ningbo University (China). The other 50 pairs were gathered from the Department of Abdominal Oncology of Zhejiang cancer hospital between 2010 and 2015. They had not got any therapies before received specimens. At the time of surgery, all tissue specimens were immediately preserved in RNA fixer (Bioteke, Beijing, China) at −80°C until use. Three of them were randomly selected for human RNA deep sequencing. Tumors were classified following the tumor‐node‐metastasis (TNM) staging system (7th ed.). Following the National Comprehensive Cancer Network (NCCN) Clinical Practice Guideline of Oncology (V.1.2012), histologic grade was evaluated. This project was approved by the Human Research Ethics Committee of Ningbo University. All participants received informed consent. Double‐blind manner was used through the overall process.

2.2. Library construction and RNA‐seq

Total RNA was extracted from three paired CRC and adjacent normal tissues using TRIzol (Ambion) according to the manufacturer's instructions and was quality controlled using Agilent 2200 (Agilent). Then, total RNA was used for library construction using TruSeq Stranded Total RNA with Ribo‐Zero Gold (Illumina). Following the manufacturer's instructions, strand‐specific RNA‐seq libraries were prepared. The libraries were quality controlled again with Agilent 2200 (Agilent) and sequenced using HiSeq X (Illumina).

2.3. RNA sequencing mapping and differentially expressed genes screen

The processed clean reads were then aligned to human genome (version: hg19_GRCh37) using the MapSplice program (v2.1.6).

We filtered the differentially expressed genes using EBSeq algorithm8 via the significant analysis including P‐value and false discovery rate (FDR) analysis under the following criteria: (a) fold change >1.5 or <0.667 and (b) FDR <0.05.9

2.4. Go analysis

Gene ontology analysis was performed to facilitate elucidating the biological implications of unique genes in the significant or representative profiles of the differentially expressed gene in the experiment. We downloaded the GO annotations from NCBI (http://www.ncbi.nlm.nih.gov/), UniProt (http://www.uniprot.org/) and the GO (http://www.geneontology.org/). Fisher's exact test was applied to identify the significant GO categories, and FDR was used to correct the P‐values.

2.5. Pathway analysis

Pathway analysis was used to find out the significant pathway of the differential genes according to Kyoto Encyclopedia of Genes and Genomes (KEGG) database (https://www.kegg.jp/). We turn to the Fisher's exact test to select the significant pathway, and the threshold of significance was defined by P‐value and FDR.10, 11, 12

2.6. Total RNA extraction, reverse transcription reaction, and qPCR

Tissue RNA was extracted using TRIzol reagents (Ambion), following the manufacturer's instructions, respectively. The A260/A280 ratio in DS‐11 Spectrophotometer (DeNovix) and 1% agarose gel electrophoresis were then used to assess the quality of RNA. Finally, total RNA was reverse transcribed to cDNA by a GoScript Reverse Transcription (RT) System (Promega).

The real‐time quantitative reverse transcription polymerase chain reaction (qRT‐PCR) was performed using GoTaq qPCR Master Mix (Promega) on an Mx3005P Real‐Time PCR System (Stratagene) following the manufacturer's instructions. Divergent primers of hsa_circ_0142527, convergent primers of KLF4, and glyceraldehyde 3‐phosphate dehydrogenase (GAPDH, as a control) were designed and synthesized by Sangon Biotech. The sequences of hsa_circ_0142527, KLF4, and GAPDH were as follows: 5′‐GGGTCCAACATCACTGACACC‐3′ and 5′‐TGTGCCTTCTCATGGTTACTACAA‐3′ for hsa_circ_0142527; 5′‐CCTTCAACCTGGCGGACATCAAC‐3′ and 5′‐GCTGCTGCGGCGGAATGTAC‐3′ for KLF4; and 5′‐ACCCACTCCTCCACCTTTGAC‐3′ and 5′‐TGTTGCTGTAGCCAAATTCGTT‐3′ for GAPDH. The conditions of thermal cycling were as follows: 5 minutes at 95°C for a hot start; then 45 cycles at 94°C for 15 seconds, 54°C for 30 seconds, and 72°C for 30 seconds.13 The cycle threshold (Ct) values of hsa_circ_0142527 and GAPDH were recorded. Targeted circRNA (hsa_circ_0142527) expression levels were calculated using the ΔCt method with GAPDH as the control.14 Lower ΔCt values mean higher expression levels.

2.7. Cloning and sequencing of qRT‐PCR products

The qRT‐PCR products of hsa_circ_0142527 and KLF4 mRNA were purified using the UNIQ‐10 PCR Product Purification Kit (Sangon Biotech) and were cloned into the pUCm‐T vector (Sangon Biotech). Finally, PCR product sequencing was performed by the same company.15

2.8. Statistical analysis

All statistical analyses are based on Statistical Program for Social Sciences (SPSS) v18.0 (SPSS, lnc.) and GraphPad Prism 5.0 (GraphPad Software, lnc.). Student's t test, one‐way analysis of variance (ANOVA), and the rank‐sum test were used according to the actual conditions. The diagnostic value of hsa‐circ‐0142527 was evaluated by receiver operating characteristic (ROC) curve. P‐values <0.05 were considered statistically significant.

3. RESULTS

3.1. Overview of RNA deep sequencing of CRC tissues

Three patient samples were chosen from a CRC cohort. Histopathology was assessed by surgical histopathological examinations, and patient characteristics are shown in Table S1.

After clean reads mapping, a detailed statistical analysis was performed to understand the overview of RNA deep sequencing in CRC tissues (data accessible at NCBI GEO database, accession GSE121842, Zhang https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121842). We found that the top three gene structures in transcriptome are exon, intron, and coding sequence (CDS) in CRC (Figure 1A). Besides, we got reads distribution on all chromosomes (Figure 1B).

Figure 1.

Figure 1

Overview of RNA deep sequencing in colorectal cancer (CRC) tissues. A, All gene structures in transcriptome. B, Chromosomes distribution of transcriptome reads in CRC tissues compared with human genome. C, Hierarchical cluster analysis showed several types of significantly differentially expressed RNAs including mRNAs, noncoding RNAs, and miscellaneous RNAs in CRC and paracancerous tissues. D, The volcano plot. The red dots in the plot represent RNA with statistical significance

Hierarchical clustering analysis showed the differential RNA expression levels between CRC and paracancerous tissues (Figure 1C). A volcano plot (Figure 1D) was constructed using fold change (FC) and false discovery rate (FDR) values to visualize the relationship between FC and statistical significance.16

3.2. Profiles of differentially expressed circRNAs in CRC

After using EBSeq algorithm, a total of 4735 circRNAs were filtered (GSE121842). Among them, 67 differentially expressed circRNAs were revealed (FC >2.0, FDR <0.05). There are 36 upregulated and 31 downregulated circRNAs, respectively. Hierarchical clustering analysis revealed expression differences of circRNAs between CRC and paracancerous tissues (Figure 2A). According to the log fold change, the top 10 upregulated and downregulated circRNAs in CRC tissue were selected (Table 1, Figure 2B). Among them, six circRNAs did not have circRNA ID in circBase (http://www.circbase.org/).

Figure 2.

Figure 2

Expression of circRNAs in colorectal cancer (CRC) tissues. A, Hierarchical cluster analysis of differentially expressed circRNAs in CRC and paracancerous tissues (FC >2, FDR <0.05). Significantly differentially expressed circRNAs between normal and malignant tissues of CRC are shown on a scale from green (low) to red (high). Individual tissues subsets are depicted as columns. B, The top 10 upregulated and downregulated circRNAs in CRC tissues

Table 1.

The top 10 upregulated and downregulated circRNAs in CRC tissues

CircRNA ID Chromosome Regulation Log2FC FDR Gene symbol Strand NO. SeqLength
circIGHV3‐30‐1a chr14 Up 20.000 0.000 IGHV3‐30 1 288 233
hsa_circ_0078617 chr6 Up 4.322 0.025 MAP3K4 + 2 1555
hsa_circ_0085558 chr8 Up 4.322 0.016 PVT1 + 3 410
hsa_circ_0003602 chr3 Up 4.229 0.008 SMARCC1 4 863
hsa_circ_0071174 chr4 Up 3.907 0.034 LRBA 5 449
hsa_circ_0067717 chr3 Up 3.672 0.026 RNF13 + 6 425
hsa_circ_0001615 chr6 Up 3.644 0.028 PHIP 7 411
circAATF‐1a chr17 Up 3.570 0.005 AATF + 8 1022
hsa_circ_0000724 chr16 Up 3.570 0.019 KLHDC4 9 407
circMGAT5a chr2 Up 3.392 0.011 MGAT5 + 10 17 456
hsa_circ_0002220 chr17 Down −3.557 0.005 MED13 10 503
hsa_circ_0008287 chr19 Down −3.913 0.007 GPATCH1 + 9 304
hsa_circ_0069865 chr4 Down −4.068 0.000 LPHN3 + 8 1702
circVPS13‐1a chr8 Down −4.115 0.004 VPS13B + 7 666
hsa_circ_0067480 chr3 Down −4.127 0.009 STAG1 6 637
hsa_circ_0000038 chr1 Down −4.577 0.005 PHACTR4 + 5 783
hsa_circ_0137008/hsa_circ_0142527 chr8 Down −4.667 0.000 PREX2 + 4 503
hsa_circ_0002578 chr15 Down −4.667 0.022 PTPN9 3 321
circIGHV3‐32‐1a chr14 Down −20.000 0.000 IGHV3‐32 2 470 687
circIGHV3‐20‐1a chr14 Down −20.000 0.000 IGHV3‐20 1 382 044
a

No circRNA ID in circBase. We named them after their host gene.

3.3. Gene ontology analysis and pathway analysis of differentially expressed circRNAs

Gene ontology analysis of the host genes which producing 67 differentially expressed circRNAs was performed to investigate the potential enriched GO. GO contains three domains: biological process (BP), molecular function (MF), and cellular components (CC).17

The enriched GO terms included 265 BPs, 141 MFs, and 93 CCs. According to the number of differential genes in a certain GO ID, the top 10 classifications of BPs, CCs, and MFs were shown (Figure 3A). Among BPs, GO:0006351 (transcription, DNA‐templated) and GO:0006355 (regulation of transcription, DNA‐templated) were the most differential genes. Among MFs, GO:0005515 (protein binding) was the most differential gene. Among CCs, GO:0005634 (nucleus) was the most differential gene. According to the (−log10 P value), the top 15 BPs, MFs, and CCs were selected (Figure 3B). The top five significant BPs were the regulation of cell morphogenesis, nucleosome disassembly, regulation of cell cycle, positive regulation of transcription, and DNA‐templated. According to the (−log10 P value) in MFs analysis, the top 15 were selected. The top five significant MFs were DNA replication origin binding, ubiquitin‐protein ligase activity, ligase activity, ubiquitin‐protein transferase activity, and beta‐mannosidase activity. According to the (−log10 P value), the top 15 CCs were selected. Origin recognition complex, nuclear origin of replication recognition complex, npBAF complex, nucleoplasm, and nBAF complex were top five significant CCs.

Figure 3.

Figure 3

Gene ontology (GO) analysis of the genes which producing 67 differentially expressed circRNAs. A, Top 10 classifications of biological processes (BPs), cellular components (CCs), and molecular functions (MFs) according to the number of linear counterparts of differentially expressed circRNAs. B, The top 15 significant BPs, MFs, and CCs according to the (−log10 P value) in GO analysis

To understand the function of differentially expressed circRNAs in CRC tissues, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was performed. According to the enrichment score, the top two significant pathways were cell cycle and other glycan degradation (Figure 4A). Interestingly, according to the (−log10 P value), the top two significant pathways also were cell cycle and other glycan degradation (Figure 4B).

Figure 4.

Figure 4

Pathway analysis of the genes which producing 67 differentially expressed circRNAs. A, The arrangement of the host genes producing differentially expressed circRNAs according to the enrichment score. B, The arrangement of the host genes producing differentially expressed circRNAs according to the (−log10 P value)

3.4. Validation of the expression levels of KLF4 in CRC and identification of differentially expressed circRNAs correlate with KLF4

Because one of circRNAs' role is acting as miRNA sponges by binding with miRNAs, we predicted circRNAs which have the same binding sites with mRNAs. For example, 15 candidate circRNAs that are KLF4 competing endogenous RNAs (ceRNAs) in CRC tissues were selected (Figure 5).

Figure 5.

Figure 5

circRNA/miRNA/KLF4 mRNA networks. KLF4 mRNA (pink circle) and 15 circRNAs (blue triangle) shared 16 miRNAs (green square)

Firstly, we verified KLF4 expression levels in paired CRC and paracancerous tissues in polycentricity. The results in both training group and confirm group showed that the expression levels of KLF4 in CRC tissues were significantly lower compared to those in paracancerous tissues (P < 0.001, Figure 6A). Then, hsa_circ_0142527 was randomly selected from 15 circRNAs which are KLF4 ceRNAs. The FC and FDR of hsa_circ_0142527 in RNA deep sequencing were −1. 821 and 0.0002, respectively. qRT‐PCR results in polycentricity indicated that hsa_circ_0142527 in CRC tissues was significantly lower compared to paracancerous tissues (P < 0.001, Figure 6B). The ROC curve was used for a comprehensive index reflecting the sensitivity and specificity of continuous variable.18 The area under the curve (AUC) of hsa_circ_0142527 in training group was 0.818 (95% CI: 0.715‐0.920, P < 0.001, Figure 6D). The optimal cut‐off value of hsa_circ_0142527 was 14.625, with sensitivity and specificity 82.9% and 80.5%, respectively. The area under the curve (AUC) of hsa_circ_0142527 in confirm group was 0.942 (95% CI: 0.896‐0.987, P < 0.001, Figure 6D). The optimal cut‐off value of hsa_circ_0142527 was 6.72, with sensitivity and specificity 87.8% and 89.8%, respectively. The expression levels of hsa_circ_0142527 and clinicopathological features were also analyzed. We found that the expression levels of hsa_circ_0142527 were significantly associated with age (P = 0.004), differentiation (P = 0.008), invasion (P = 0.029), distal metastasis (P = 0.004), TNM stage (P = 0.005), and carcinoembryonic antigen (CEA; P = 0.037; Table 2). Besides, we sequenced the qRT‐PCR products and confirmed the existence of KLF4 mRNA and hsa_circ_0142527 in CRC tissues (Figure 6C). In addition, we found that KLF4 and hsa_circ_0142527 have high positive correlation (Figure 7; r = 0.754, P < 0.001).

Figure 6.

Figure 6

KLF4 mRNA and hsa_circ_0142527 expression levels in paired colorectal cancer (CRC) and paracancerous tissues in training and confirm groups. A, KLF4 expression levels in CRC and paracancerous tissues were detected by qRT‐PCR method. Training group (left): n = 39, ***P < 0.001. Confirm group (right): n = 49, ***P < 0.001. B, hsa_circ_0142527 expression levels in paired CRC and paracancerous tissues were detected by qRT‐PCR method. Training group (left): n = 41, ***P < 0.001. Confirm group (right): n = 49, ***P < 0.001. C, Sequencing results of KLF4 mRNA (top) and hsa_circ_0142527 (below) of qRT‐PCR products. D, The receiver operating characteristic (ROC) curves of hsa_circ_0142527 in polycentricity. Training group (left): the area under the curve (AUC) was 0.818 (95% CI: 0.715‐0.920, P < 0.001). Confirm group (right): the AUC was 0.942 (95% CI: 0.896‐0.987, P < 0.001)

Table 2.

The relationships between the expression levels of hsa_circ_0142527 and clinicopathological features of CRC patients

Characteristics No. of cases (%) Mean ± SD P‐value
Age (y)
≥55 65 (72.2) 12.585 ± 4.284 0.004*
<55 25 (27.8) 9.934 ± 3.549  
Gender
Male 56 (62.2) 12.495 ± 4.236 0.063
Female 34 (37.8) 10.784 ± 4.101  
Tumor location
Colon 35 (38.9) 12.816 ± 4.347 0.085
Rectum 55 (61.1) 11.233 ± 4.100  
Diameter (cm)
≥5 36 (40.0) 12.061 ± 4.407 0.701
<5 54 (60.0) 11.707 ± 4.169  
Differentiation
Well and moderate 77 (85.6) 11.660 ± 4.178 0.008*
Poor 13 (14.4) 8.014 ± 1.940  
Invasion
T1 & T2 & T3 32 (35.6) 13.176 ± 4.105 0.029*
T4 58 (64.4) 11.117 ± 4.211  
Lymphatic metastasis
N0 44 (48.9) 12.444 ± 4.376 0.185
N1‐2 46 (51.2) 11.239 ± 4.119  
Distal metastasis
M0 65 (72.2) 12.627 ± 3.905 0.004*
M1 25 (27.8) 9.824 ± 4.499  
TNM stage
I & II & III 64 (71.1) 12.620 ± 3.936 0.005*
IV 26 (28.9) 9.824 ± 4.499  
CA19‐9
Positive 15 (16.7) 10.667 ± 4.433 0.241
Negative 75 (83.3) 12.124 ± 4.201  
CEA
Positive 29 (32.2) 10.550 ± 4.511 0.037*
Negative 61 (67.8) 12.545 ± 3.989  
*

P < 0.05.

Figure 7.

Figure 7

KLF4 and hsa_circ_0142527 have high positive correlation. (r = 0.754, r 2 = 0.568,P < 0.001)

4. DISCUSSION

CircRNAs are a large class of endogenous RNAs in eukaryote. Because of the properties of abundant, stable, diverse, and conserved, circRNAs are involved in various diseases.19 Bachmayr‐Heyda et al20 firstly reported that a global reduction of circular RNA abundance in CRC cell lines and cancer tissues showed a negative correlation of global circular RNA abundance and proliferation. Zeng et al12 showed that CircHIPK3 promoted CRC growth and metastasis by sponging miR‐7. Zeng et al21 detected 431 differentially expressed circRNAs from CRC tissues of patients with lung metastasis and constructed circRNA/miRNA interactions, They demonstrated that hsa_circ_102761, hsa_circ_086376, and hsa_circ_105055 bonded with miR‐7 and regulated target genes EPHA3, PRKCB, BRCA1, and ABCC1 in CRC with lung metastasis.21 Besides, Zhang et al22 demonstrated that hsa_circ_0020397 regulated CRC cell viability, invasion, and apoptosis by promoting the expression of miR‐138 targets TERT and PD‐L1. Xie et al23 revealed the regulatory mechanism of hsa_circ_001569/miR‐145/E2F5, BAG4, FMNL2 axis in cell proliferation and invasion in CRC.

In this study, we performed a human RNA deep sequencing to explore the circRNAs expression profiles in CRC (Figure 1). We found 67 differentially expressed circRNAs, 36 upregulated and 31 downregulated circRNAs, respectively (Figure 2). Among the top 10 upregulated and downregulated circRNAs in CRC, six circRNAs had no circRNA ID in circBase (Table 1). These circRNAs may be new circRNAs. Besides, all the top 10 upregulated and 10 downregulated circRNAs were not found in CRC cancer tissues before October 24, 2018, in the literatures from PubMed (https://www.ncbi.nlm.nih.gov/pubmed/). These results provide new information for further understanding the occurrence of CRC.

One major mechanism of circRNAs is acting as miRNAs to regulate gene expression. It is now well established that KLF4 (also called gut‐enriched Krüppel‐like factor or GKL)24 is a key suppressor gene in CRC involved in multiple key CRC pathways such as Notch pathway and Wnt/β‐catenin pathway.25, 26, 27, 28, 29 A number of miRNAs can bind to the 3′‐untranslated region (3′‐UTR) of KLF4 mRNA.25, 26, 27, 30, 31, 32, 33, 34 Hence, we predicted 15 candidate circRNAs as KLF4 ceRNA in CRC tissues (Figure 5). Hsa_circ_0142527 was selected as a targeted circRNA to validate the accuracy of RNA deep sequencing. Our results showed that hsa_circ_0142527 in CRC was significantly lower compared to matched paracancerous tissues (Figure 6). The area under the ROC curves was 0.702 (Figure 6D). More importantly, the expression levels of hsa_circ_0142527 were significantly associated with age, differentiation, invasion, distal metastasis, TNM stage, and carcinoembryonic antigen (CEA; Table 2). The moderate correlations between KLF4 and hsa_circ_0142527 were documented (Figure 7).

Nowadays, whether circRNAs can regulate host genes is controversial. Du et al35 found that over‐expressed circ‐DNMT1 increased the mRNA level of the parent gene DNMT1. A recent study indicated that circITGA7 inhibited CRC growth and metastasis by modulating Ras pathway and upregulating transcription of its host gene ITGA7.36 Besides, circEIF3J and circPAIP2 showed interactions with RNA Pol II, U1 snRNP, and parental gene promoters to promote the transcription of host genes.37 These results indicate that some circRNAs can regulate their host genes.

Furthermore, we performed GO analysis of the host genes producing the differentially expressed circRNAs. The top five significant BPs were regulation of cell morphogenesis, nucleosome disassembly, regulation of cell cycle, positive regulation of transcription, and DNA‐templated (Figure 3). It was required for transcription controls that underlie differentiation, development, and tumor suppression.38 Another previous study also revealed apoptosis‐antagonizing transcription factor (AATF), one number of differentially expressed circRNA circAATF‐1, was involved in transcriptional regulation, cell cycle control, DNA damage responses, and in the execution of cell death programs.39 GO analysis showed that the occurrence and progress of CRC were co‐regulated by differentially expressed circRNAs from different functional systems (Figure 3). Moreover, according to the enrichment score or (−log10 P value), the top 2 pathways were cell cycle and other glycan degradation (Figure 4). In our study, three differentially expressed circRNAs (ORC4, STAG1, and ORC2) were predicted involved in cell cycle.

In conclusion, our study provided a circRNA expression profiles in CRC and established a network among miRNAs, mRNAs, and circRNAs in CRC. We also firstly demonstrated that hsa_circ_0142527 may be a potential new biomarker for the diagnosis of CRC.

Supporting information

ACKNOWLEDGMENTS

This study was supported by grants from Natural Science Foundation of Ningbo (No. 2016A610121), the Scientific Innovation Team Project of Ningbo (No. 2017C110019), and the K.C. Wong Magna Fund in Ningbo University.

Ge J, Jin Y, Lv X, et al. Expression profiles of circular RNAs in human colorectal cancer based on RNA deep sequencing. J Clin Lab Anal. 2019;33:e22952 10.1002/jcla.22952

REFERENCES

  • 1. Peng H‐X, Yang L, He B‐S, et al. Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I‐III stage CRC. J Clin Lab Anal. 2017. 10.1002/jcla.22075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Li T, Shao Y, Fu L, et al. Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT‐PCR detection. J Mol Med. 2018;96:85‐96. [DOI] [PubMed] [Google Scholar]
  • 3. Fu L, Jiang Z, Li T, Hu Y, Guo J. Circular RNAs in hepatocellular carcinoma: functions and implications. Cancer Med. 2018;7:3101‐3109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Yao T, Chen Q, Fu L, Guo J. Circular RNAs: biogenesis, properties, roles, and their relationships with liver diseases. Hepatol Res. 2017;47:497‐504. [DOI] [PubMed] [Google Scholar]
  • 5. Wang J, Li X, Lu L, He L, Hu H, Xu Z. Circular RNA hsa_circ_0000567 can be used as a promising diagnostic biomarker for human colorectal cancer. J Clin Lab Anal. 2018. 10.1002/jcla.22379 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384‐388. [DOI] [PubMed] [Google Scholar]
  • 7. Hitzemann R, Bottomly D, Darakjian P, et al. Genes, behavior and next‐generation RNA sequencing. Genes Brain Behav. 2013;12:1‐12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Leng N, Dawson JA, Thomson JA, et al. EBSeq: an empirical Bayes hierarchical model for inference in RNA‐seq experiments. Bioinformatics. 2013;29:1035‐1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125:279‐284. [DOI] [PubMed] [Google Scholar]
  • 10. Khatri P, Voichita C, Kattan K, et al. Onto‐Tools: new additions and improvements in 2006. Nucleic Acids Res. 2007;35:W206‐W211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Kanehisa M, Goto S, Kawashima S, et al. The KEGG resource for deciphering the genome. Nucleic Acids Res. 2004;32:D277‐D280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Zeng K, Chen X, Xu MU, et al. CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR‐7. Cell Death Dis. 2018;9:417. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 13. Shao Y, Ye M, Jiang X, et al. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer. Cancer. 2014;120:3320‐3328. [DOI] [PubMed] [Google Scholar]
  • 14. Shao Y, Li J, Lu R, et al. Global circular RNA expression profile of human gastric cancer and its clinical significance. Cancer Med. 2017;6:1173‐1180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Chen S, Li T, Zhao Q, Xiao B, Guo J. Using circular RNA hsa_circ_0000190 as a new biomarker in the diagnosis of gastric cancer. Clin Chim Acta. 2017;466:167‐171. [DOI] [PubMed] [Google Scholar]
  • 16. de Almeida RMC, Clendenon SG, Richards WG, et al. Transcriptome analysis reveals manifold mechanisms of cyst development in ADPKD. Hum Genomics. 2016;10:37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663‐676. [DOI] [PubMed] [Google Scholar]
  • 18. Zhao Q, Chen S, Li T, Xiao B, Zhang X. Clinical values of circular RNA 0000181 in the screening of gastric cancer. J Clin Lab Anal. 2017; 10.1002/jcla.22333 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2012; 19: 141 ‐ 157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Bachmayr‐Heyda A, Reiner AT, Auer K, et al. Correlation of circular RNA abundance with proliferation–exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues. Sci Rep. 2015;5:8057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Zeng Y, Xu YU, Shu R, et al. Altered expression profiles of circular RNA in colorectal cancer tissues from patients with lung metastasis. Int J Mol Med. 2017;40:1818‐1828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Zhang XL, Xu LL, Wang F. Hsa_circ_0020397 regulates colorectal cancer cell viability, apoptosis and invasion by promoting the expression of the miR‐138 targets TERT and PD‐L1. Cell Biol Int. 2017;41:1056‐1064. [DOI] [PubMed] [Google Scholar]
  • 23. Xie H, Ren X, Xin S, et al. Emerging roles of circRNA_001569 targeting miR‐145 in the proliferation and invasion of colorectal cancer. Oncotarget. 2016;7:26680‐26691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Ghaleb AM, Yang VW. The pathobiology of kruppel‐like factors in colorectal cancer. Curr Colorectal Cancer Rep. 2008;4:59‐64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Zhang GJ, Li LF, Yang GD, et al. MiR‐92a promotes stem cell‐like properties by activating Wnt/beta‐catenin signaling in colorectal cancer. Oncotarget. 2017;8:101760‐101770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Jie Y, He W, Yang X, et al. Kruppel‐like factor 4 acts as a potential therapeutic target of Sijunzi decoction for treatment of colorectal cancer. Cancer Gene Ther. 2017;24:361‐366. [DOI] [PubMed] [Google Scholar]
  • 27. Hu R, Zuo Y, Zuo LI, et al. KLF4 expression correlates with the degree of differentiation in colorectal cancer. Gut Liv. 2011;5:154‐159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Fu J, Tang W, Du P, et al. Identifying microRNA‐mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis. BMC Syst Biol. 2012;6:68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Chen H‐Y, Lin Y‐M, Chung H‐C, et al. miR‐103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res. 2012;72:3631‐3641. [DOI] [PubMed] [Google Scholar]
  • 30. Zhai F, Cao C, Zhang L, et al. miR‐543 promotes colorectal cancer proliferation and metastasis by targeting KLF4. Oncotarget. 2017;8:59246‐59256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Wang T, Xu H, Liu X, Chen S, Zhou YI, Zhang X. Identification of key genes in colorectal cancer regulated by miR‐34a. Med Sci Monit. 2017;23:5735‐5743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Tokarz P, Blasiak J. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment. Acta Biochim Pol. 2012;59:467‐474. [PubMed] [Google Scholar]
  • 33. Tang W, Zhu Y, Gao J, et al. MicroRNA‐29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E‐cadherin via KLF4. Br J Cancer. 2014;110:450‐458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Lv H, Zhang Z, Wang Y, Li C, Gong W, Wang X. MicroRNA‐92a promotes colorectal cancer cell growth and migration by inhibiting KLF4. Oncol Res. 2016;23:283‐290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Du WW, Yang W, Li X, et al. A circular RNA circ‐DNMT1 enhances breast cancer progression by activating autophagy. Oncogene. 2018; 37: 5829‐5842. [DOI] [PubMed] [Google Scholar]
  • 36. Li X, Wang J, Zhang C, et al. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7. J Pathol. 2018;246:166‐179. [DOI] [PubMed] [Google Scholar]
  • 37. Bonizzato A, Gaffo E, te Kronnie G, Bortoluzzi S. CircRNAs in hematopoiesis and hematological malignancies. Blood Cancer J. 2016;6:e483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Wang X, Liao D‐W, Scoy MV, Pacchione S, Yaciuk P, Moran E. Monoclonal antibodies reactive with the BAF155 (SMARCC1) and BAF170 (SMARCC2) components of human SWI/SNF‐related complexes. Hybridoma. 2005; 24: 55‐57. [DOI] [PubMed] [Google Scholar]
  • 39. Sharma M. Apoptosis‐antagonizing transcription factor (AATF) gene silencing: role in induction of apoptosis and down‐regulation of estrogen receptor in breast cancer cells. Biotechnol Lett. 2013;35:1561‐1570. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES